Get Breaking Business News headlines emailed to you daily.
InterMune Shares Jump On FDA Panel Recommendation Source: Fox Business Tuesday 9th March, 2010
SAN FRANCISCO -- InterMune Inc. shares jumped after a Food and Drug Administration panel recommended the agency approve the biotech's Esbriet lung treatment.